Gus D. Halas is Director at OptimizeRx Corp (OPRX). They have made 5 open-market trades across 2 companies since 2013, most recently 2024-06-05.
CIK 0001230322
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $124K since 2013, never a sale. Across 5 scored buys the stock is down 1.3% at ninety days, and 4.5 points behind the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 20% | 20% | 20% |
| Avg Move | -1.9% | -3.1% | -1.3% |
| Alpha | -13.9% | -3.5% | -4.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPRX | BUY | 2019-11-13 | 2019-11-13 | $9.80 | $49K | +11.5% | +0.8% | +9.8% |
| OPRX | BUY | 2017-03-20 | 2017-03-21 | $0.77 | $17K | -1.4% | -1.0% | -1.0% |
| OPRX | BUY | 2017-03-09 | 2017-03-15 | $0.74 | $6K | -1.4% | -1.0% | -1.0% |
| OPRX | BUY | 2015-10-06 | 2015-10-07 | $1.26 | $13K | -1.4% | -1.0% | -1.0% |
| HH | BUY | 2013-09-03 | 2013-09-05 | $0.40 | $40K | -16.8% | -13.4% | -13.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.